{"DataElement":{"publicId":"6034302","version":"1","preferredName":"Non-Native Protein Expression Cellular Therapy Product Insertion Type","preferredDefinition":"A description of the non-native protein that was inserted into the cellular therapy product.","longName":"6034294v1.0:6034141v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"6034294","version":"1","preferredName":"Non-Native Protein Expression Cellular Therapy Product Insertion","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction._Of or related to the original state or source; natural._The biosynthesis of new (often sets of distinct, functionally related) protein products, usually involving new mRNA transcripts, typically in response to an activating stimulus._Utilization of specific cells, modified or not, for treatment of diseases. Donor lymphocyte infusion is a type of cellular therapy._A thing produced by or resulting from a process. EXAMPLE(S): drug, device. The FDA list of regulated products: animal and human drugs; therapeutic biologics; allergenics; cell, tissue and gene therapy products; blood components; blood derivative products; devices; and animal (pets and livestock) and human food/feed (medicated and un-medicated); cosmetics; pet treats; and dietary supplements._The act of putting one thing into another.","longName":"6034291v1.0:6034292v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"6034291","version":"1","preferredName":"Negation Native Protein Expression","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.:Of or related to the original state or source; natural.:The biosynthesis of new (often sets of distinct, functionally related) protein products, usually involving new mRNA transcripts, typically in response to an activating stimulus.","longName":"C25594:C73789:C18966","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Native","conceptCode":"C73789","definition":"Of or related to the original state or source; natural.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Protein Expression","conceptCode":"C18966","definition":"The biosynthesis of new (often sets of distinct, functionally related) protein products, usually involving new mRNA transcripts, typically in response to an activating stimulus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F26627D-BD31-0606-E053-F662850AC34B","latestVersionIndicator":"Yes","beginDate":"2017-11-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-11-29","modifiedBy":"ONEDATA","dateModified":"2017-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6034292","version":"1","preferredName":"Cellular Therapy Product Insertion","preferredDefinition":"Utilization of specific cells, modified or not, for treatment of diseases. Donor lymphocyte infusion is a type of cellular therapy.:The end result of a manufacturing process; anything that is produced.:The act of putting one thing into another.","longName":"C70601:C51980:C48685","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cellular Therapy","conceptCode":"C70601","definition":"Utilization of specific cells, modified or not, for treatment of diseases. Donor lymphocyte infusion is a type of cellular therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Product","conceptCode":"C51980","definition":"The end result of a manufacturing process; anything that is produced.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Insertion","conceptCode":"C48685","definition":"The act of putting one thing into another.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F26627D-BD43-0606-E053-F662850AC34B","latestVersionIndicator":"Yes","beginDate":"2017-11-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-11-29","modifiedBy":"ONEDATA","dateModified":"2017-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F26627D-BD54-0606-E053-F662850AC34B","latestVersionIndicator":"Yes","beginDate":"2017-11-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-11-29","modifiedBy":"NYCHM","dateModified":"2018-02-12","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6034141","version":"1","preferredName":"Non-Native Protein Expression Type","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction._Of or related to the original state or source; natural._The biosynthesis of new (often sets of distinct, functionally related) protein products, usually involving new mRNA transcripts, typically in response to an activating stimulus._Something distinguishable as an identifiable class based on common qualities.","longName":"6034141v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Suicide gene","valueDescription":"Suicide Gene","ValueMeaning":{"publicId":"6034142","version":"1","preferredName":"Suicide Gene","longName":"6034142","preferredDefinition":"A gene which will cause a cell to kill itself, typically through interaction with a prodrug.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Suicide Gene","conceptCode":"C132840","definition":"A gene which will cause a cell to kill itself, typically through interaction with a prodrug.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F25F44F-CCF9-032E-E053-F662850AB1FB","latestVersionIndicator":"Yes","beginDate":"2017-11-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-11-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5F25F44F-CD12-032E-E053-F662850AB1FB","beginDate":"2017-11-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-11-29","modifiedBy":"ONEDATA","dateModified":"2017-11-29","deletedIndicator":"No"},{"value":"Chimeric Antigen Receptor (CAR)","valueDescription":"Chimeric Antigen Receptor","ValueMeaning":{"publicId":"5156182","version":"1","preferredName":"Chimeric Antigen Receptor","longName":"5156182","preferredDefinition":"A cell-surface receptor that has been engineered to combine novel features and specificities from various sources in order to enhance its antigen specificity. Engineered T-cells or B-cells will produce the specialized receptor that will be capable of binding to an epitope on its target cell.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chimeric Antigen Receptor","conceptCode":"C126108","definition":"A cell-surface receptor that has been engineered to combine novel features and specificities from various sources in order to enhance its antigen specificity. Engineered T-cells or B-cells will produce the specialized receptor that will be capable of binding to an epitope on its target cell.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2E18BFE4-8FFF-CA26-E050-BB89AD4332A4","latestVersionIndicator":"Yes","beginDate":"2016-03-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5F25EEB4-2616-05EB-E053-F662850A14C8","beginDate":"2016-03-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-11-29","modifiedBy":"ONEDATA","dateModified":"2017-11-29","deletedIndicator":"No"},{"value":"T-cell receptor","valueDescription":"T-Cell Receptor","ValueMeaning":{"publicId":"4385453","version":"1","preferredName":"T-Cell Receptor","longName":"4385453","preferredDefinition":"Heterodimeric antigen receptors present on the surface of T-cells.  Two T-cell antigen receptors have been identified, consisting of heterodimeric 40-55 kD Ig-like alpha/beta or gamma/delta integral membrane glycoproteins.  Genes for TCR alpha, beta, gamma, and delta subunits are assembled during T-cell development by somatic rearrangement of germline gene segments, resembling B-cell Ig genes in their mechanisms of diversity generation and activation of expression.  Alpha/beta heterodimers are found on helper and cytotoxic T-cells and are specific for antigenic peptides presented by MHC gene products.  T-cells expressing gamma/delta heterodimers directly recognize proteins and non-proteinacious phospho-ligands.  T-cell receptors are non-covalently associated with CD3, forming the TCR-CD3 complex.  TCRs activate MAPKs and JNK1 through the CD3 antigens, the adaptor protein LAT, and tyrosine kinases LCK and ZAP70.  (from OMIM and NCI)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T-Cell Receptor","conceptCode":"C17065","definition":"Heterodimeric antigen receptors present on the surface of T-cells.  Two T-cell antigen receptors have been identified, consisting of heterodimeric 40-55 kD Ig-like alpha/beta or gamma/delta integral membrane glycoproteins.  Genes for TCR alpha, beta, gamma, and delta subunits are assembled during T-cell development by somatic rearrangement of germline gene segments, resembling B-cell Ig genes in their mechanisms of diversity generation and activation of expression.  Alpha/beta heterodimers are found on helper and cytotoxic T-cells and are specific for antigenic peptides presented by MHC gene products.  T-cells expressing gamma/delta heterodimers directly recognize proteins and non-proteinacious phospho-ligands.  T-cell receptors are non-covalently associated with CD3, forming the TCR-CD3 complex.  TCRs activate MAPKs and JNK1 through the CD3 antigens, the adaptor protein LAT, and tyrosine kinases LCK and ZAP70.  (from OMIM and NCI)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE3DCA1E-C67A-7605-E040-BB89AD4320BD","latestVersionIndicator":"Yes","beginDate":"2014-07-15","endDate":null,"createdBy":"COLBERTM","dateCreated":"2014-07-15","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5F25EEB4-2620-05EB-E053-F662850A14C8","beginDate":"2016-03-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-11-29","modifiedBy":"ONEDATA","dateModified":"2017-11-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2861582","version":"1","preferredName":"Role","preferredDefinition":"The values that are permitted for the usual or expected function of something; the part something plays in an action or event. [Source: NCI]","longName":"ROLE","context":"NCIP","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"67F34359-7D35-ED41-E040-BB89AD437390","latestVersionIndicator":"Yes","beginDate":"2009-04-19","endDate":null,"createdBy":"DWARZEL","dateCreated":"2009-04-19","modifiedBy":"DWARZEL","dateModified":"2009-04-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6034140","version":"1","preferredName":"Negation Native Protein Expression Type","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.:Of or related to the original state or source; natural.:The biosynthesis of new (often sets of distinct, functionally related) protein products, usually involving new mRNA transcripts, typically in response to an activating stimulus.:Something distinguishable as an identifiable class based on common qualities.","longName":"C25594:C73789:C18966:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Native","conceptCode":"C73789","definition":"Of or related to the original state or source; natural.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Protein Expression","conceptCode":"C18966","definition":"The biosynthesis of new (often sets of distinct, functionally related) protein products, usually involving new mRNA transcripts, typically in response to an activating stimulus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F25EEB4-25EF-05EB-E053-F662850A14C8","latestVersionIndicator":"Yes","beginDate":"2017-11-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-11-29","modifiedBy":"ONEDATA","dateModified":"2017-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F25EEB4-2600-05EB-E053-F662850A14C8","latestVersionIndicator":"Yes","beginDate":"2017-11-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-11-29","modifiedBy":"NYCHM","dateModified":"2018-02-12","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"CTP_CPM_n_na_prot_expr_ct_ty","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the non-native prote","type":"Preferred Question Text","description":"What was the non-native protein that was inserted into the cellular therapy product?","url":null,"context":"NHLBI"},{"name":"Specify the protein inserted into the cellular product","type":"Alternate Question Text","description":"Specify the protein inserted into the cellular product","url":null,"context":"NHLBI"},{"name":"Specify the protein inserted into the cellular product","type":"Application Standard Question Text","description":"Specify the protein inserted into the cellular product","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F25EEB4-262D-05EB-E053-F662850A14C8","latestVersionIndicator":"Yes","beginDate":"2017-11-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-11-29","modifiedBy":"NYCHM","dateModified":"2018-02-12","changeDescription":".; System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}